⌕
Caris Life Sciences · CAI · Nasdaq
Tenet 40 · Weak
Compare
$21.00−8.85%At closeTenet 40 · Weak
$21.00−2.04 (−8.85%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Caris Life Sciences (CAI) Key Ratios

Valuation, quality, health and growth. Every ratio ranked against its sector peers — the number we score — with its own ten-year record shown beside it for context.

Sources Company filings and market prices Filings and pricesRatios computed How we compute thisNot investment advice

31 figures withheld by our checks. Each blank figure names its reason.

12
VALUE
High multiples vs sector
premium price vs peers
61
QUALITY
Decent
mid-pack profitability
47
HEALTH
Stable
manageable balance sheet
—
GROWTH
Not scored
no measurable growth rate; left out of the composite

A decent business at high multiples for its sector: value 12, quality 61, health 47, each a percentile within Healthcare.

Values are the trailing twelve months where a company files quarterly statements and the figure passes our check against the filings, with balance-sheet ratios from the most recent quarter; otherwise, or where a sector's figure is still under review, the latest fiscal year. Piotroski and the five-year growth rates are fiscal years. Each row names its period.track = where peers land, worse → better (direction-adjusted: right always means better)▏sector median● you are here▲ where today's value sits in the company's own ten fiscal years (context, not scored)hover any metric for its formula
12th pctilepremium price vs peers
Earnings yield (EBIT/EV)EBIT (operating income) for the latest fiscal year ÷ enterprise value on the current market cap (Greenblatt). The vendor's own earnings yield is net income to common ÷ market cap, a different figure.—Withheld: the balance sheet has no cash line, so enterprise value and net debt are not measured.
P/E70.814th pctileown record too short
P/B10.617th pctileown record too short
P/FCF235.25th pctileown record too short
EV / EBITDA—Withheld: the balance sheet has no cash line, so enterprise value and net debt are not measured.
47th pctilemanageable balance sheet
Current ratio6.7177th pctileown record too short
Quick ratio(Cash, short-term investments and receivables) ÷ current liabilities, as the data vendor builds it. Its receivables include non-trade receivables, which Tenet's balance sheet shows inside other current assets.—Withheld: the balance sheet has no cash line, so enterprise value and net debt are not measured.
Net debt / EBITDA(Total debt − cash) ÷ EBITDA—Withheld: this figure is outside the range we accept for its kind.
Interest coverage3.3×31st pctileown record too short
Debt / equity0.6233rd pctileown record too short
61st pctilemid-pack profitability
ROIC13%80th pctileown record too short
ROE17%76th pctileown record too short
Gross margin69.1%54th pctileown record too short
Net margin9.2%66th pctileown record too short
Income quality (CFO/NI)0.87×12th pctileown record too short
Piotroski F6 / 969th pctileown record too short
Altman Z5.969th pctileown record too short
no measurable growth rate; left out of the composite
Revenue CAGRThe yearly rate that compounds the earliest fiscal year's revenue into the latest one, over the true number of fiscal years between them (up to five). When the earliest year's revenue is zero or negative, the rate starts from the first later year with at least $10M of revenue, provided at least three years remain.—This growth figure starts in a period outside the history your plan includes.
EPS CAGR—This growth figure starts in a period outside the history your plan includes.
FCF margin2.8%36th pctileown record too short
the receipts behind the numbers above
Greenblatt earnings yield—EBIT ÷ EV The vendor's "earningsYield" is NI ÷ market cap, which is not Greenblatt's formula.
ROIC13%NOPAT ÷ invested capital The vendor's simple ROIC, not its tiny-base roic tag; withheld when a negative EBIT flips its sign.
Interest coverage3.3× EBIT ÷ interest expense, ranked within sector peers.
Percentiles computed nightly against 313 Healthcare peers from our ingested fundamentals DB · raw statements for corrected metrics. Direction-adjusted: for "lower is better" ratios (P/E, D/E…) the percentile is flipped so right always means better. The percentile is the stock's rank among sector peers, the number that is scored. The triangle marks where the current value (the trailing twelve months or the latest fiscal year, as its row names) sits in the company's own ten fiscal-year record, shown for context and never blended into the score. Computed Nov 13, 2026 · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.